Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Gastric cancer

Risk analysis

Intestinal metaplasia (IM) is a pre-cancerous condition, and connected with an increased risk of developing intestinal-type gastric adenocarcinoma, the most common form of gastric cancer (GC). However, only a small subset of IM patients develop GC. In a 10-year prospective study, Huang, Ramnarayanan, Zhu, Srivastava et al. performed (epi)genomic profiling of 138 IMs from 148 GC-free patients to determine molecular features, including Helicobacter pylori (Hp) status, associated with GC progression or IM regression. Compared with GCs, IMs had low frequencies of clonal mutations. IMs with somatic copy number alterations (sCNAs), telomere erosion and epigenomic alterations were associated with GC progression, indicating that epigenomic changes observed in a subset of IMs can be targeted to reduce GC progression. Finally, Hp-positive IMs were detected by sequencing at a higher rate than by histology, and were more likely to harbour sCNAs.

References

  1. 1

    Huang, K. K. et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell 33, 137–150 (2018)

    CAS  Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Harjes, U. Risk analysis. Nat Rev Cancer 18, 66 (2018). https://doi.org/10.1038/nrc.2018.9

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing